The company stated that no generic versions of semaglutide are currently available and described compounded alternatives as "unapproved fake or illegitimate knockoffs" that could "expose patients to serious safety and efficacy risks." As part of their effort to address this issue, Novo Nordisk has advocated for semaglutide to be added to the FDAs list of drugs that present "demonstrable difficulties for compounding." FDAs Decision and Timelines In February, the FDA declared that the semaglutide shortage was officially over
Retrieved from frontiersin: About The Authors: Nasim Pourarian works as a research analyst at iData Research, where she is responsible for developing and compiling syndicated research projects focused on the medical device industry
MXN $128.00 * Precio exclusivo de tienda en lnea
GLP-1RA is safe for use in children and adolescents over the age of 10 years, and some formulations have been approved for pediatric T2DM or obesity
Are injection site reactions worse with compounded GLP-1 medications
However, current systematic conclusions about weight regain mostly came from the studies of bariatric surgery or behavioral interventions